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In vitro tumor models have provided important tools for cancer research and serve as 
low-cost screening platforms for drug therapies; however, cancer recurrence remains 
largely unchecked due to metastasis, which is the cause of the majority of cancer-related 
deaths. The need for an improved understanding of the progression and treatment of 
cancer has pushed for increased accuracy and physiological relevance of in vitro tumor 
models. As a result, in vitro tumor models have concurrently increased in complexity and 
their output parameters further diversified, since these models have progressed beyond 
simple proliferation, invasion, and cytotoxicity screens and have begun recapitulating 
critical steps in the metastatic cascade, such as intravasation, extravasation, angio-
genesis, matrix remodeling, and tumor cell dormancy. Advances in tumor cell biology, 
3D cell culture, tissue engineering, biomaterials, microfabrication, and microfluidics 
have enabled rapid development of new in vitro tumor models that often incorporate 
multiple cell types, extracellular matrix materials, and spatial and temporal introduction of 
soluble factors. Other innovations include the incorporation of perfusable microvessels 
to simulate the tumor vasculature and model intravasation and extravasation. The drive 
toward precision medicine has increased interest in adapting in vitro tumor models for 
patient-specific therapies, clinical management, and assessment of metastatic potential. 
Here, we review the wide range of current in vitro tumor models and summarize their 
advantages, disadvantages, and suitability in modeling specific aspects of the metastatic 
cascade and drug treatment.
Keywords: tumor models, transwell assay, spheroids, metastasis, microvessel models
iNTRODUCTiON
In vitro and in vivo animal models are important tools in cancer research, enabling the iden-
tification of carcinogens, the development of cancer therapies, drug screening, and providing 
insight into the molecular mechanisms of tumor growth and metastasis. In the series of steps 
that comprise the metastatic process, cancer cells migrate or flow through vastly different 
microenvironments, including stroma, blood vessel endothelium, the vascular system, and 
the tissue at a secondary site (Chambers et  al., 2002; Fidler, 2003; Steeg, 2006). The ability 
TABLe 1 | In vitro tumor models.
Model Phenomena
Transwell-based models
Migration Migration, intravasation, extravasation, drug screening
Invasion Invasion, intravasation, extravasation, matrix 
remodeling, drug screening
Transendothelial 
migration
Intravasation, drug screening
Spheroid-based models
Spheroids in media Growth/proliferation, drug screening
Spheroids in gels Growth/proliferation, invasion, matrix remodeling, 
angiogenesis, drug screening
Coculture Invasion, angiogenesis, drug screening, immune 
interactions
Hybrid models
Embedded ex vivo 
tumor sections
Tumor growth, invasion, matrix remodeling, drug 
screening
3D invasion models Invasion, matrix remodeling, angiogenesis, dormancy
Avascular microfluidic 
models
Migration, extravasation
Tumor-microvessel models
Predefined ECM 
scaffold
Invasion, intravasation, extravasation, angiogenesis, 
dormancy, drug delivery
Microvessel 
self-assembly
Invasion, intravasation, extravasation, angiogenesis, 
dormancy, drug delivery
Tumor models can be broadly classified as transwell-based, spheroid-based, hybrid 
platforms, and tumor-microvessel models. Each model has the ability to model different 
processes in the progression and spread of cancer.
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to successfully negotiate each of these steps is dependent on 
the interactions between the cancer cell and the local micro-
environment (Wirtz et  al., 2011). Metastasis is responsible 
for more than 90% of cancer-related deaths (Weigelt et  al., 
2005; Mehlen and Puisieux, 2006); however, many details of 
the steps in the metastatic cascade remain poorly understood 
(Wirtz et al., 2011).
A wide range of mouse models have been developed of pri-
mary and metastatic tumors, including environmentally induced 
models, human tumor xenografts in immunocompromised mice, 
and genetically engineered mice (Cekanova and Rathore, 2014; 
Denayer et al., 2014). While in vivo models capture the complex-
ity of the metastatic process in a living system, visualization of 
the individual steps is challenging and extracting quantitative 
mechanistic data is usually very difficult. In contrast, in  vitro 
models have reduced physiological relevance, capturing only 
limited aspects of the tumor microenvironment, but allow control 
of most experimental variables and permit quantitative analysis.
In vitro models of solid tumors vary in complexity and 
range from tumor-derived cell lines to 3D models of the tumor 
microenvironment (Hulkower and Herber, 2011; Wirtz et  al., 
2011; Infanger et al., 2013; Vidi et al., 2013). Models have been 
developed to provide mechanistic insight into tumor growth/
proliferation, migration, invasion, matrix remodeling, dormancy, 
intravasation, extravasation, angiogenesis, and drug delivery. 
Model variables include cell sources (patient cells, commercially 
available cell lines, stem cells, stromal cells, immune cells, etc.), 
biophysical properties (oxygen partial pressure, pH, interstitial 
flow, etc.), extracellular matrix (ECM) (stiffness, architecture, 
etc.), and biochemical cues (chemoattractants, angiogenic fac-
tors, etc.). The complexity of the model is largely dependent on 
the objectives. For example, preliminary screening of anticancer 
drugs can be performed in cell culture. Studies of invasion and 
motility of tumor cells can be performed with cells embedded in 
an ECM. Studies of intravasation and extravasation necessitate 
a microenvironment that incorporates one or more perfusable 
microvessels.
A key component of any in  vitro tumor model is a source 
of cancer cells. Cancer cell lines are easy to grow, allow direct 
comparison of experimental results, and are widely used to study 
molecular mechanisms of tumor cell biology (Greshock et  al., 
2007; Holliday and Speirs, 2011). The molecular profiles of a large 
number of human cancer cell lines are available in the Cancer Cell 
Line Encyclopedia (Barretina et al., 2012), and these profiles can 
be compared to the profiles of a large number of human tumors, 
compiled as part of the Cancer Genome Atlas Research Network 
(Holliday and Speirs, 2011; Cancer Genome Atlas Research 
Network et  al., 2013; Domcke et  al., 2013). Patient-derived 
tumorgrafts capture the heterogeneity of cells in a tumor, and in 
some cases, the tumor histomorphology and global gene expres-
sion profile (DeRose et  al., 2011); however, engraftment into a 
mouse or matrix material exerts a selection pressure that changes 
the clonal composition (Luca et al., 2013; Aparicio et al., 2015). In 
addition, patient-derived samples provide limited ability for com-
parison of experimental results. Irrespective of the cell source, 
models are by definition approximations of a tumor, designed to 
recapitulate specific aspects of the tumor microenvironment.
Advances in tumor cell biology, 3D cell culture, tissue 
engineering, biomaterials, microfabrication, and microfluidics 
have enabled rapid development of in vitro tumor models. New 
models are characterized by increased complexity through the 
incorporation of multiple cell types (coculture), ECM materials, 
and spatial and temporal introduction of soluble factors. Here, we 
review the current state-of-the-art in in vitro tumor models. For 
convenience, models are broadly categorized as transwell-based, 
spheroid-based, hybrid platforms, and tumor-microvessel mod-
els. We summarize the advantages and disadvantages of these 
models, identify the components of the tumor microenviron-
ment that can be varied, and the phenomena that can be studied 
(Table 1). This review serves as a guide to selection of in vitro 
platforms best suited to specific applications in tumor biology.
TRANSweLL-BASeD MODeLS
introduction
Transwell-based assays are widely used to assess cancer cell 
migration and invasion (Figure 1) (Hulkower and Herber, 2011; 
Marshall, 2011; Kramer et al., 2013). Migration is the movement of 
cells from one location to another and is central to the metastatic 
cascade (Madsen et al., 2015). Cell migration may be random or 
directed by gradients in soluble factors, electric field, or matrix 
stiffness (Rorth, 2009; Madsen et al., 2015). Invasion refers to the 
migration of cells in a 3D ECM (Friedl and Alexander, 2011; Friedl 
et al., 2012a). The three commonly used variations of transwell-
based assays are (1) migration assays, (2) invasion assays, and 
FiGURe 1 | Types of transwell-based motility assays. Migration, invasion, and transendothelial migration setups can all be used to assay multiple parameters, 
such as the relative invasiveness of different cells and the effect of drugs or gene manipulation on motility.
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(3) transendothelial migration assays (Table  2). Migration, the 
simplest variation, involves seeding cancer cells directly on a 
porous membrane, while invasion assays involve seeding cells on 
a layer of ECM material on top of the porous membrane (Kramer 
et al., 2013). Transendothelial migration assays involve a conflu-
ent layer of endothelial cells on top of the membrane (Smith 
et al., 1991). Transwell-based assays are usually combined with 
a chemoattractant gradient, typically media with 10% FBS in the 
bottom chamber and media with ≤1% FBS in the upper chamber 
(Marshall, 2011; Kramer et al., 2013). Other common chemoat-
tractants include individual growth factors (Carter and Church, 
2012), ECM proteins (Kao et  al., 2008), and paracrine signals 
from other cell types (e.g., fibroblasts) (Underwood et al., 2015).
Migration Assays
The migration assay involves seeding cancer cells on top of a 
porous membrane (typically with 8  μm pores) and quantify-
ing the number of cells that can migrate across the membrane 
toward a chemoattractant (Marshall, 2011). Cells are typically 
fixed after 24–72  h for imaging. Staining with either a nuclear 
stain or crystal violet is common for counting the migrated 
cells (Marshall, 2011). The bottom surface of the membrane is 
imaged and typically quantified by cells per imaging field. While 
this is a simplistic assay, the degree of migration through pores 
toward serum provides a high throughput in vitro model of tumor 
intravasation through leaky vasculature, with the pores in the 
membrane representing the gaps in the endothelium and serum 
representing the bloodstream (Pouliot et al., 2000).
invasion Assays
Invasion assays add another level of complexity to this model. 
A layer of ECM is deposited on the porous membrane to model 
the basement membrane of the vasculature. This layer is typically 
Matrigel (Marshall, 2011), although collagen (Wang et al., 2010), 
and laminin (Rath et al., 2013) are also used. ECM layers can range 
in thickness up to 1 mm (Kramer et al., 2013). While migration 
TABLe 2 | Advantages and disadvantages of transwell-based tumor 
models.
Transwell 
model
Description Advantages Disadvantages
Migration Cancer cells pass 
through transwell 
membrane, 
analogous to leaky 
endothelium
•  Easily 
implemented, 
low-cost 
assay
•  High 
throughput
•  Can be used 
to compare 
metastatic 
potential of 
cells
•  Low 
physiological 
relevance
•  Can only assay 
single-cell 
motility
•  Migration and 
invasion assays 
can result in 
conflicting data
Invasion Cancer cells pass 
through a layer 
of ECM and the 
transwell membrane
Transendothelial 
migration
Cancer cells pass 
through a monolayer 
of endothelial cells to 
assay extravasation
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and invasion assays probe very similar properties of cells, it is 
worth noting that some drugs and gene manipulations have a 
stronger effect on the reduction of invasion than migration. For 
example, when transfected to overexpress TPFR-2, which inhibits 
MMP activity, PANC-1 pancreatic cancer cells show no reduction 
in migration but a 60% reduction in invasion (Tang et al., 2010). 
In another study, it was found that siRNA knockdown of IMP3 
resulted in decreased expression of CD-44, reduced migration by 
30% while decreasing invasion by 80% (Pasiliao et al., 2015).
Transendothelial Migration Assays
Transendothelial migration assays involve plating a confluent 
monolayer of endothelial cells onto the porous support. This 
model has the additional complexity of the cell–cell junctions 
between endothelial cells and the ECM that they produce (Smith 
et al., 1991). In this configuration, transendothelial assays pro-
vide a good model of extravasation, as cancer cells must first 
pass through the endothelium and then the deposited basement 
membrane (Rahn et al., 2005). This assay can also be inverted to 
model intravasation by growing endothelial cells on the bottom 
side of the transwell membrane to confluence and seeding cancer 
cells in the top chamber (Pignatelli et al., 2014). These transen-
dothelial assays are most commonly used to study brain capillary 
endothelium, which have tight cell–cell junctions (Lin et  al., 
2015), although other endothelial cell types, such as HUVECs 
(Pignatelli et al., 2014), are used as well.
Applications of Transwell-Based Assays
Transwell methods are used for drug screening and to study 
migration, intravasation, extravasation, and matrix remodeling. 
In most cases, transwell-based assays involve counting the 
number of cells that are able to translocate across the porous 
membrane under the experimental conditions. Many tumor cell 
lines exhibit a threefold to fivefold increase in the number of cells 
translocating across the membrane compared to non-cancerous 
cells (Li and Zhu, 1999), while drug and gene therapies typically 
reduce invasion by 30–80% (Tang et  al., 2010; Lin et  al., 2015; 
Yang et al., 2015). Applications of transwell-based assays include 
(1) studies of the influence of chemoattractants on migration and 
invasion (Orellana et  al., 2015), (2) studies of the influence of 
other cell types (e.g., macrophages and fibroblasts) on invasion 
of cancer cells (Pignatelli et al., 2014), (3) studies of the relative 
rates of invasion, migration, intravasation, and extravasation of 
different cell types (Li and Zhu, 1999), (4) the isolation of inva-
sive/non-invasive cell types for molecular analysis (Kao et  al., 
2008), (5) testing the influence of knockdown, transfection, and 
antibody treatment on invasion and migration (Gan et al., 2015), 
(6) assessing drug therapies in reducing invasion (Yang et  al., 
2015), and (7) basic studies of the role of soluble factors on inva-
sion (Carter and Church, 2012). As an example of the application 
of transwell-based assays, renal cancer cells from patients with 
bone metastases showed a 20-fold increase in migration toward 
calcium compared to cells from patients that had not metasta-
sized (Joeckel et al., 2014). This study illustrates how a relatively 
straightforward in vitro assay can be used as a diagnostic tool to 
assess the ability of a patient’s primary tumor to metastasize to a 
specific secondary site.
SPHeROiDS
introduction
Spheroids are aggregates of cells grown in suspension or 
embedded in a 3D matrix using 3D culture methods (Figure 2) 
(Mueller-Klieser, 1987; Gottfried et  al., 2006; Hirschhaeuser 
et  al., 2010; LaBarbera et  al., 2012; Fennema et  al., 2013). 
Cancer cell spheroids, known as multicellular tumor spheroids 
(MCTS), represent avascular tumor nodules or micro-metastases 
(Friedrich et al., 2009). While more expensive and time consum-
ing compared to 2D cell culture, 3D spheroids are widely used for 
drug screening and studies of tumor growth and proliferation, 
immune interactions, and for the case of spheroids embedded 
in a matrix, studies of invasion, matrix remodeling, and angio-
genesis (Mueller-Klieser, 1987; Gottfried et  al., 2006; Friedrich 
et al., 2007; Hirschhaeuser et al., 2010; LaBarbera et al., 2012). 
3D spheroids recapitulate cell–cell and cell–matrix interactions 
between tumor cells and the microenvironment (Hirschhaeuser 
et al., 2010; Mehta et al., 2012; Fennema et al., 2013), as well as 
transport properties (Mehta et al., 2012). Larger spheroids sustain 
oxygen and nutrient gradients that often result in the formation of 
a necrotic core similar to poorly vascularized tumors (Friedrich 
et al., 2009). Spheroids also demonstrate proliferation gradients 
and zones reminiscent of tumors (Mueller-Klieser, 1987). As a 
result of these factors, the protein and gene expression profiles 
of tumor cells in spheroids are much closer to clinical and in vivo 
gene expression profiles than those in 2D culture (Friedrich et al., 
2009; LaBarbera et al., 2012).
An important variable in MCTS is tumor size since it is corre-
lated with cell function, as well as drug penetration and transport. 
In general, spheroids between 200 and 500 μm are sufficiently 
large to develop gradients of oxygen, nutrients, and catabolites 
(Hirschhaeuser et al., 2010). Above a critical size of 400–600 μm, 
spheroids develop a central secondary necrosis where the inner-
most cells die of apoptosis or necrosis (Gottfried et  al., 2006; 
Friedrich et  al., 2009; Hirschhaeuser et  al., 2010). These larger 
spheroids generally have a viable cell rim that is 100–300  μm 
thick around the necrotic core (Gottfried et al., 2006). Spheroids 
as small as 200 μm have been used for drug testing and may be 
FiGURe 2 | Summary of spheroid-based assays including spheroid formation techniques, experimental setups, variables to study, and experimental 
outputs.
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sufficient to recapitulate cell–cell and cell–matrix interactions but 
are not large enough to recapitulate oxygen gradients with hypoxic 
regions or proliferation gradients (Friedrich et al., 2009). The time 
to culture a 400-μm spheroid (seeded at a density of 500 cells per 
well) is around 4 days but is dependent on cell type (Friedrich 
et al., 2009). For short-term culture (<48 h), spheroids may not be 
as densely packed as spheroids that have been cultured for longer 
and may not recapitulate cell–cell and cell–matrix interactions.
Spheroid Formation
There are four general methods of spheroid formation 
(Figure  2), each with their distinct advantages and disad-
vantages (Table  3): suspension culture, non-adherent surface 
methods, hanging drop methods, and microfluidic methods 
(Mehta et  al., 2012). Suspension culture methods promote 
spheroid formation by maintaining cells in suspension through 
agitation or by increasing the viscosity of the media (e.g., with 
the addition of carboxymethyl cellulose), thereby enabling 
spontaneous aggregation (Lin and Chang, 2008; Metzger et al., 
2011). Suspension culture has high throughput but does not 
allow control of size and uniformity (Lin and Chang, 2008; 
Mehta et al., 2012).
Culturing cells on non-adherent surfaces prevents attach-
ment to the substrate and promotes spheroid formation. In the 
liquid overlay technique (LOT), suspended cells are cultured on 
a non-adherent surface, such as agar, 1–1.5% agarose, or poly-
HEMA (Yuhas et al., 1977; Ivascu and Kubbies, 2006; Metzger 
et al., 2011). Using non-adherent surfaces is straightforward 
but does not allow control over spheroid size and uniformity. 
Growth of spheroids in microarrays greatly increases through-
put while allowing control of spheroid size (Hsiao et al., 2012; 
Mehta et al., 2012; Fennema et al., 2013). Spheroid growth can 
be directed using round-bottom non-adherent 96-well plates 
or stamped agarose microwells (Fennema et al., 2013).
The hanging drop method and techniques that employ 
microfluidic devices are more complex but allow better control 
of spheroid size and composition (Mehta et  al., 2012). In the 
hanging drop technique, droplets of cells are suspended from 
the underside of an adherent tissue culture lid. Gravity drives 
cell aggregation into a cluster at the bottom of the drop, which 
then grows into a spheroid (Kelm et al., 2003). The hanging drop 
TABLe 3 | Advantages and disadvantages of tumor spheroid models.
Spheroid-
forming 
method
Description Advantages Disadvantages
Cell suspension 
culture
Spheroids 
are cultured 
in suspension 
to avoid 
sedimentation and 
adherence
• Simple
•  Mass production
•  Long-term 
culture
•  No individual 
compartments 
for spheroids
•  Cannot control 
uniformity (size, 
composition)
•  High shear 
force
Non-adherent 
surfaces
Spheroids are 
induced to form 
on planar non-
adherent surfaces 
or microarray wells 
(MW)
• Simple
•  Better efficiency 
(MW)
•  High throughput 
(MW)
•  Uniform spheroid 
size (MW)
•  Coculture (MW)
•  Low 
throughput
•  Long-term 
culture difficult
Hanging drop 
technique
Hanging droplets 
of spheroids from 
underside of lid
•  Control of 
spheroid size
•  Uniform spheroid 
size
•  Allows coculture 
with defined cell 
types
•  Low 
throughput
•  Long-term 
culture difficult
•  Not efficient
Microfluidic 
devices
Spheroids are 
generated within 
microfluidic 
channels
•  Control of 
spheroid size
•  Control of 
spheroid growth 
parameters
•  Continuous 
perfusion
•  Faster spheroid 
formation
•  Difficulty 
collecting cells 
for analysis
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technique is relatively straightforward and allows for uniform 
spheroid size but is relatively low throughput, partially due to the 
necessity of manual media changes.
Microfluidic devices are becoming increasingly common since 
they allow precise control of spheroid formation (Wu et al., 2008; 
Mehta et al., 2012; Fu et al., 2014). Continuous perfusion under 
physiological conditions during spheroid formation allows for 
faster formation and increased size uniformity (Mehta et al., 2012). 
Microfluidic platforms also allow the formation, maintenance, 
and testing of spheroids within a single device (Wu et al., 2008).
Applications of Tumor Spheroids
Spheroids have been used in four main applications: the study of 
cell function (e.g., cell proliferation, migration, and invasion) in 
an avascular tumor microenvironment, the development of new 
therapies and drug screening, the study of tumor angiogenesis, and 
the study of tumor–immune cell interactions (Mueller-Klieser, 
1987; Gottfried et al., 2006; Lin and Chang, 2008; Hirschhaeuser 
et al., 2010; Fennema et al., 2013).
Cell Function
Early studies of spheroids focused on recapitulating solid tumors 
and studying growth kinetics (size versus time), composition, 
and tumor cell biology (e.g., proliferation, differentiation, cell 
death, protein and gene expression, etc.) (Sutherland et al., 1971; 
Freyer and Sutherland, 1986; Durand, 1990; Friedrich et  al., 
2009). Studies comparing gene expression profiles of spheroids 
and 2D cultures to resected tumors revealed differences in genes 
associated with cell survival, proliferation, differentiation, and 
resistance to drug therapy and showed that spheroids more 
closely resembled in vivo tumors (Hirschhaeuser et al., 2010).
The ability of cells to migrate is a hallmark of the epithelial to 
mesenchymal transition (Gagliano et al., 2005). Cell migration 
assays have been developed to test therapeutics and their ability 
to reduce tumor cell migration and inhibit their transition to 
an invasive, metastatic phenotype (Rao et al., 2005; Vinci et al., 
2013). Invasion studies are performed by placing spheroids on 
coated surfaces (i.e., vitronectin-coated) or embedding in gels 
(i.e., collagen type I) and measuring their invasiveness, as well 
as analyzing factors involved in matrix degradation and tumor 
invasion, such as cathepsin-B and matrix metalloproteinases 
(MMP) (Tamaki et al., 1997; Lakka et al., 2004; Wolf et al., 2007; 
Ilina et al., 2011).
Drug Screening
Cancer spheroids are widely used to assess tumor response and 
sensitivity to chemotherapeutics, combination therapies (e.g., 
chemotherapeutics and small molecule inhibitors), targeted 
chemotherapy, and drug delivery vehicles (L’Esperance et  al., 
2008; Perche et al., 2012; Mikhail et al., 2013; Sarisozen et al., 
2014). Spheroids are commonly used as a high-throughput 
tool for negative selection of drug candidates to reduce animal 
testing (Friedrich et al., 2009) and for positive selection in new 
drug development (Hirschhaeuser et al., 2010). Drug screening 
typically involves spheroid formation, incubation with a drug, 
measurement of spheroid integrity and growth kinetics (growth 
delay and regrowth), and measurement of cell survival (e.g., 
acid phosphatase assay and colony formation assay) (Friedrich 
et al., 2007, 2009; Hirschhaeuser et al., 2010). The colony forma-
tion assay is used to measure the ability of a single cell to grow 
into a colony and is used to assess clonogenic survival (Franken 
et al., 2006; Hirschhaeuser et al., 2010). Overall, MCTS are more 
resistant to treatment than cells in 2D culture (Lin and Chang, 
2008; Mehta et al., 2012; Fennema et al., 2013) and can reca-
pitulate the drug resistance observed in solid tumors (Friedrich 
et al., 2009).
Angiogenesis
The potential for tumor vascularization is often assessed from 
the migration of endothelial cells into tumor spheroids or the 
formation of vascular networks within spheroids (Timmins et al., 
2004). Protocols include the culture of MCTS on endothelial cell 
monolayers, coculture of MCTS spheroids and EC spheroids, and 
spheroids formed from a mixture of tumor cells and endothelial 
cells (Jadhav et al., 2004; Timmins et al., 2004; Ghosh et al., 2007; 
Upreti et  al., 2011). Tumor-induced angiogenesis can increase 
oxygen consumption and increase expression of hypoxia-related 
and proangiogenic genes (Wartenberg et al., 2001). Other stud-
ies have focused on factors that induce or inhibit angiogenesis, 
such as MMP-9 which plays a key role in endothelial network 
February 2016 | Volume 4 | Article 127
Katt et al. In Vitro Tumor Models
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
organization (Jadhav et al., 2004). 3D spheroid coculture models 
are increasingly used in tissue engineering to modulate angio-
genesis (Korff and Augustin, 1998; Korff et  al., 2001; Wenger 
et al., 2004, 2005).
Immune Cell Response
The immune system plays an important role in the antitumor 
response that is primarily driven by natural killer cells, dendritic 
cells, and macrophages (Hickey and Kubes, 2009; Pardoll, 2012; 
Gajewski et al., 2013). The tumor-immune response is assessed by 
culturing MCTS with immune cells and observing the migration 
and infiltration of immune cells or by forming spheroids from 
tumor cells and immune cells and observing the interactions 
and cytotoxic effects of immune cells within tumor spheroids 
(Gottfried et  al., 2006). Tumor cells often secrete factors that 
induce an immunosuppressive environment. For example, the 
lactic acid-rich environment surrounding tumors inhibits the 
cytotoxic activity of T-lymphocytes (CTLs) (Fischer et al., 2007) 
and reduces the migration of monocytes (Gottfried et al., 2006). 
Tumor spheroids are also being used to develop therapeutic 
strategies to stimulate an immune response by promoting infiltra-
tion and cytotoxicity of various immune cells (Durek et al., 1999; 
Hoffmann et al., 2009).
HYBRiD MODeLS
introduction
There are several types of in vitro tumor models that cannot be 
classified as spheroid- or transwell-based. These include embed-
ded ex vivo tumor sections, 3D invasion models, and avascular 
microfluidic models (Figure  3). These models combine the 
complexity of the tumor microenvironment while maintaining 
the relative simplicity of an in vitro model (Table 4). Embedded 
ex vivo tumor sections from patient biopsies can be used to select 
individualized chemotherapeutic regimens and fundamental 
studies of tumor growth and invasion (Yabushita et  al., 2004). 
3D invasion models reduce some of the complexities involved 
in the embedded biopsy samples by allowing clear visualization 
of specific cell interactions and interrogation of a wide range of 
events in the metastatic cascade. Avascular microfluidic models 
are the simplest in this category but still incorporate a wide range 
of techniques to interrogate the migration of tumor cells in a 
variety of geometries.
embedded Ex Vivo Tumor Sections
The use of tumor biopsies or resected tumors sections embed-
ded in an ECM has been employed to interrogate the tumor 
microenvironment in vitro (Miller et al., 1984, 1986; Dark et al., 
1997; Kobayashi et al., 1997; Yamada et al., 1999; Brown et al., 
2004; Xu et  al., 2013). Embedded biopsies or tumor sections 
maintain the heterogeneity of tumor cell subpopulations, sup-
porting tissue cells, and the tumor vasculature. While the tumor 
vasculature is not perfusable in these models, it is a valuable 
tool for characterization and study as it removes many of the 
in  vivo complexities but maintains the cell interactions. This 
technique is largely used for characterization of tumor morphol-
ogy, growth, and chemosensitivity (Dark et  al., 1997) and has 
potential as a technique for screening patient-specific therapies 
(Xu et al., 2013).
Tumor sections are typically embedded in collagen type I as 
a mimic of the ECM (Nguyen-Ngoc et al., 2012), although it has 
been shown that the gene expression and phenotypic profiles of 
the cancer cells are dependent on the matrix material (Kievit 
et al., 2010; Nguyen-Ngoc et al., 2012). Genes associated with 
cell adhesion, such as the cadherins, integrins, and lectins, were 
significantly downregulated in experiments where disseminat-
ing cancer cells were isolated from a 3D collagen type I matrix 
(Nguyen-Ngoc et  al., 2012). Embedded tumor sections have 
been used to characterize the growth and invasion of brain 
(Tsuchida et  al., 1998; Yamada et  al., 1999) and mammary 
tumors (Miller et al., 1984, 1986) and have been used to study 
drug penetration into the tumor (Netti et al., 2000; Ramanujan 
et al., 2002; Brown et al., 2004).
The most common use of embedded tissue sections is the 
culture-drug sensitivity test (CD-DST), where cells from a 
patient-derived tumor are cultured in collagen droplets and 
incubated with different anticancer drugs, and the chemosensi-
tivity is assessed from the number of remaining viable cells. This 
technique has been compared to the outcomes of patients with 
a wide variety of tumor types (Kobayashi et al., 1997; Hanatani 
et  al., 2000) and is currently in clinical trials as a tool in the 
patient-specific treatment of cancer (Yabushita et al., 2004).
3D invasion Models
While the embedded spheroid and embedded tumor section 
models can be used to image global growth, protrusion forma-
tion, and detachment and invasion of individual tumor cells, 3D 
invasion models focus specifically on invasion by seeding indi-
vidual or clusters of cancer cells in an ECM material, and thus 
reducing some of the complexities of the tumor microenviron-
ment. Live cell imaging is used to determine cell morphology and 
track the trajectories of individual cells allowing quantification 
of cell speed and persistence through the ECM. This approach 
can be used to study the role of ECM material, matrix stiffness, 
chemotactic gradients, and hypoxia on cell adhesion, invasion, 
and matrix remodeling (Liu et al., 2010; Sung et al., 2011; Koch 
et al., 2012; Kim et al., 2013; Shen et al., 2014; Mosadegh et al., 
2015). Coculture variations of 3D invasion models often include 
a monolayer of fibroblasts, endothelial cells, or cancer cells on 
a matrix material with cancer cells or fibroblasts embedded in 
the matrix. These models can be used to study the influence of 
proangiogenic factors secreted by the tumor cells, as well as che-
moattractants secreted by endothelial cells or fibroblasts (Krause 
et al., 2010; Liu et al., 2010; Shen et al., 2014; Horie et al., 2015).
Avascular Microfluidic Models
Avascular microfluidic devices are primarily used to assess 
cancer cell migration along small channels with respect to 
chemotactic gradients. Many avascular microfluidic devices 
study migration along small confined channels that are designed 
to mimic the quasi one-dimensional migration between fibers 
in the ECM (Fraley et al., 2010; Wirtz et al., 2011; Friedl et al., 
2012b; Konstantopoulos et al., 2013). Microfluidic devices allow 
well-defined gradients of chemoattractants and other molecules 
TABLe 4 | Advantages and disadvantages of hybrid tumor models.
Model Description Advantages Disadvantages
Embedded 
ex vivo tumor 
sections
•  Primary tumor 
sections 
or biopsies 
embedded 
in gel
•  Maintains tumor 
heterogeneity
•  Patient-specific 
assay
•  Mimics outgrowth 
into surrounding 
tissues
•  Lacks flow 
through 
vasculature
3D invasion 
models
•  Tumor cells 
or clusters 
embedded in 
a gel
•  3D 
microenvironment
•  Allows real-time 
tracking of cells
•  Balance of 
complexity and 
experimental 
control
•  Lacks 
vasculature
•  Lacks tumor 
complexity
Avascular 
microfluidic
•  Tumor cells 
grown in a 2D 
microfluidic 
device, typically 
for the study of 
migration
•  Simple migration 
assay
•  Easy to isolate 
effect of variables
•  Allows real-time 
tracking of cells
•  Lacks 
vasculature
•  Typically lacks 
3D environment
FiGURe 3 | Hybrid models include embedded ex vivo tumor sections, 3D invasion models, and avascular microfluidic models.
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across the channels, as well as control of oxygen partial pressure, 
and other stimuli (Guan et al., 2015). The channels can be coated 
with different adhesion proteins and/or matrix materials to 
modulate cell adhesion or can be filled with ECM to simulate 
confined migration in 3D (Chaw et al., 2007; Hou et al., 2009). 
As with other in  vitro tumor models, multiple cell types can 
also be introduced (Liu et al., 2010; Ma et al., 2010; Gao et al., 
2011). Experimental measurements typically involve using live 
cell microscopy to determine cell speed along the channels as a 
function of experimental conditions (channel dimensions, the 
presence of obstacles, coating/ECM materials, solute gradients, 
etc.) (Chaw et al., 2007; Hou et al., 2009). Studies in microfluidic 
channels have contributed to the discovery of genes required for 
cancer cell migration and identification of proteins, such as EGFR 
or CXCL12, that act as chemoattractants for cancer cells (Saadi 
et al., 2006; Torisawa et al., 2010).
Microfluidic models have been used to study cancer cell adhe-
sion to endothelial monolayers as a precursor to extravasation. 
In these models, a monolayer of endothelial cells is formed in 
a microfluidic channel, and cancer cells are subsequently intro-
duced into the channel over the endothelial monolayer at a fixed 
flow rate. Using live cell microscopy, the adhesion and rolling of 
the cancer cells can be studied as a function of shear stress with 
or without inhibitors or antibodies for adhesion molecules. These 
studies have shown that E-selectin and CXCL12 are important 
endothelial receptors for cancer cell adhesion (Tözeren et  al., 
1995; Khaldoyanidi et al., 2003; Song et al., 2009; Hsu et al., 2011).
TUMOR-MiCROveSSeL MODeLS
introduction
The tumor vasculature is an important component of the tumor 
microenvironment providing nutrients essential for growth. 
The endothelial cells lining blood vessels are known to secrete 
factors that both promote and suppress tumor growth (Butler 
FiGURe 4 | Schematic illustration of the microvessel fabrication process and interactions between the microvessel and tumor cells in the 
surrounding extracellular matrix (eCM). (A) A solution form of ECM, often collagen type I or fibrin, laden with cells is introduced around the cylindrical template 
within the PDMS housing. After gelation/cross-linking, the template rod is removed. Endothelial cells are introduced and line the interior of the cylindrical channel. (B) 
Upper left inset, cylindrical channel lined with endothelial cells embedded within an ECM. The figure shows a cross-section of a cylindrical vessel interacting with 
tumor cells in multiple ways. Tumor cells may secrete growth factors and cytokines that promote angiogenesis from a nearby vessel. Tumor cells may invade and 
intravasate within the local vasculature. Tumor cells within the circulating media may extravasate by adhering to the vessel wall, transmigrating across the 
endothelium, and invading into the ECM.
TABLe 5 | Advantages and disadvantages of tumor-microvessel models.
Tumor-microvessel 
model
Platform Application Advantages Disadvantages
Predefined ECM 
scaffold
Cylindrical template/scaffold Invasion and intravasation •  Well-defined vessel endothelium 
and shear stress
Limited vessel diameter ranges 
(>50 μm) and simple linear 
geometries
Cylindrical template/scaffold Vessel paracrine signaling with 
respect to varying shear stresses
Cylindrical template/scaffold Transvascular migration
Microfluidic-confined ECM Intravasation and extravasation
Microvessel 
self-assembly
Microfluidic-confined ECM Extravasation •  Generates vessel sizes from 
capillaries to small microvessels 
(5–50 μm) and complex networks
Random vessel network with 
unpredictable flow Microfluidic-confined ECM Drug toxicity screening
Free gel Tumor cell dormancy
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et al., 2010; Ghajar et al., 2013). Furthermore, the tumor vascu-
lature plays a critical role in several key events in the metastatic 
cascade, such as invasion, intravasation, and extravasation. The 
complex interplay between the tumor vasculature and cancer 
cells can be studied using in vitro tumor models that incorporate 
microvessels.
Microvessels used to study interactions between tumor cells 
and the tumor vasculature are generally fabricated by seeding 
endothelial cells onto predefined ECM scaffolds or self-assembled 
through matrix remodeling after randomly dispersing endothe-
lial cells within an ECM (Figure 4) (Bogorad et al., 2015). Each 
approach has advantages and disadvantages depending on the 
application (Table 5).
Predefined eCM Scaffold
Cylindrical microvessels with diameters as small as 50 μm can 
be fabricated using subtractive templating methods. These 
microvessels are generated by seeding endothelial cells on the 
internal surface of a predefined channel in an ECM, typically 
collagen type I or fibrin. Cells seeded on these ECM surfaces 
will self-assemble into a continuous monolayer and can be tested 
for functional properties, such as vessel permeability, expression 
of relevant junctional proteins, and appropriate response to 
vascular mediators and inflammatory cytokines (Chrobak et al., 
2006). These 3D cylindrical microvessels exhibit a physiologi-
cally relevant geometry, can be maintained under shear stress, 
and cocultured with a variety of cell types. While it is possible to 
incorporate smooth muscle cells, pericytes, and lymphatic drain-
age within these models, the lack of such vessel characteristics 
is a hallmark of irregularly formed tumor vasculature (Hanahan 
and Weinberg, 2011; Zheng et al., 2012; Wong et al., 2013). The 
coculture of endothelial-lined microvessels with tumor cells 
permits the study of a variety of tumor–endothelial interactions, 
such as endothelial paracrine signaling, tumor-driven angiogen-
esis, intravasation, and extravasation (Figure 4) (Buchanan et al., 
2014; Wong and Searson, 2014; Wang et al., 2015). The extrac-
tion of tumor cells from the surrounding ECM and analysis of 
their gene expression has shown that tumor cell invasiveness is 
mediated by the presence of microvessels and vessel shear stress 
(Buchanan et al., 2014). Live cell imaging of cocultured artificial 
microvessels with tumor cells in the surrounding ECM has reca-
pitulated interactions thought to occur during cancer metastasis, 
such as invasion, tumor-driven angiogenesis, intravasation, and 
extravasation (Wong and Searson, 2014; Wang et  al., 2015). 
FiGURe 5 | Schematic illustration of a microfluidic device used for 
coculturing endothelial and tumor cells. (A) 3D schematic overview of a 
microfluidic device composed of an extracellular matrix (ECM) confined within 
PDMS posts and separating two media channels. (B) Cross-section of the 
coculturing device showing multiple interactions between tumor cells and a 
seeded endothelium. Tumor cells within the ECM may elicit an angiogenic 
response from the endothelium. Tumor cells introduced in the opposite media 
channel may invade through the ECM and intravasate across the opposing 
endothelium. Tumor cells introduced in the endothelial channel may 
extravasate by transmigrating across the endothelium and invading the ECM. 
(C) Endothelial cells premixed with the ECM may self-organize into a vessel 
network of capillaries and microvessels. The microvessels may anastomose 
with the separate media compartments and permit flow. Tumor cells 
introduced into one compartment may be circulated through the microvessel 
network, adhere to the vessel walls, and extravasate.
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Qualitative observations of invasion and intravasation suggest 
that one mechanism of tumor cell entry into the vasculature is 
mediated by tumor cell activation and division at the ECM–vessel 
interface resulting in mechanical disruption of the endothelial 
monolayer (Wong and Searson, 2014).
As a variation of the predefined scaffold model, ECM is 
deposited between two microfluidic channels and a monolayer 
of endothelial cells formed on the exposed ECM in one channel, 
while tumor cells are seeded in the opposing channel (Figure 5). 
These devices have been used to image invasion, intravasation, 
extravasation, and tumor-driven angiogenesis under static flow 
conditions and have the potential to be used as high-throughput 
screens for cancer invasiveness (Zervantonakis et al., 2012; Jeon 
et al., 2013; Lee et al., 2014).
Microvessel Self-Assembly
The aforementioned devices establish the vessel endothelium by 
seeding endothelial cells on predefined ECM surfaces and are thus 
limited to generating microvessels typically larger than 50 μm in 
diameter due to limitations in uniform cell seeding. To achieve 
microvessels on the capillary scale, approximately 10–20 μm in 
diameter, endothelial cells can be embedded within a matrix and 
allowed to self-assemble into a random vessel network (Figure 5). 
Perfusion through these vessels can be established once the net-
works have connected or anastomosed with nearby media ports 
or channels (Moya et  al., 2013). Once perfusion is established, 
tumor cells may be circulated through the small diameter vessels, 
adhere to the vessel walls, and extravasate into the surrounding 
ECM (Chen et  al., 2013). Tumor cells embedded within the 
surrounding ECM on the periphery of self-assembled vessel 
networks can be both activated or arrested in a dormant state due 
to interactions with the vessel endothelium (Ghajar et al., 2013).
SUMMARY AND FUTURe PROSPeCTS
In vitro models allow researchers to recapitulate aspects of the 
tumor microenvironment using specific cell types, extracellular 
matrices, and soluble factors. Controlling the various compo-
nents of the model enables investigation of interactions within 
the tumor microenvironment, as well as the response to stimuli 
such as chemotherapeutics. There is a wide range of tumor mod-
els, each with distinct advantages and disadvantages. Due to the 
inherent differences in complexity and functionality, the choice of 
model is usually dependent on the application. A disadvantage of 
the wide range of tumor models is the lack of standard protocols 
and the difficulty in comparing results from different models. 
This problem will be exacerbated by the increase in the range and 
complexity of models available to researchers.
Transwell-based models are widely used to study migration 
and invasion of cancer cells across a porous membrane, or 
intravasation or extravasation across an endothelial monolayer, 
in a simple, high-throughput 2D platform. The next generation 
of transwell models will incorporate patient-specific cells to assay 
migration potential as a diagnostic tool. The incorporation of 
target cancer cells or biopsy samples in the basolateral chamber 
is a high-throughput approach to combining assessment of drug 
transport, uptake, and efficacy in a single assay.
Multicellular tumor spheroids recapitulate the 3D architecture 
and transport phenomena of tumor tissues and can be used to 
investigate growth and proliferation of tumor tissues, invasion 
into ECM, angiogenesis, immune interactions, and drug screen-
ing. Spheroids are able to recapitulate the basic 3D structure 
of tumors, including multicellular structure, central necrosis, 
and proliferation gradients depending on tumor type. The 
next-generation spheroid models will likely exploit advances in 
embedding in ECM and coculture with other cell types, such as 
immune cells, to elucidate immune cell interactions. Microfluidic 
devices are increasingly used to form spheroids and perform 
rapid drug screening.
Hybrid models, such as embedded ex vivo tumor sections, are 
useful for investigating tumor growth, invasion, matrix remod-
eling, and drug screening using patient biopsies. 3D invasion 
models, in which single cells are embedded in a 3D ECM, are 
used to study invasion, matrix remodeling, angiogenesis, and 
dormancy. Avascular microfluidic models are used to study the 
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tumor microenvironment, including migration and extravasa-
tion. Hybrid models, in particular embedded tumor sections 
and 3D invasion models, are well suited for patient-specific drug 
screening and predicting outcomes.
Tumor-microvessel models build on the complexity of avascu-
lar microfluidic models by introducing a vessel component and 
are particularly well suited for modeling tumor–vessel interac-
tions over time and investigating angiogenesis, vessel-induced 
tumor cell dormancy, intravasation, or extravasation. Current 
tumor-microvessel models represent a reductive approach to 
studying metastasis, where at a minimum, a functional vessel 
lined with endothelial cells and cocultured with tumor cells 
is required. Sustained perfusion of the vessels improves their 
physiological relevance and their adaptability to live cell imaging 
permits the study of the mechanistic details behind intravasation 
and extravasation. Recent advances in quantifying gene expres-
sion within these models may be applied to understanding the 
biochemical interactions between vessels and tumor cells (e.g., 
angiocrine and tumor paracrine signaling) that determine 
tumor cell proliferation and dormancy and govern tumor-driven 
angiogenesis. Future work may improve our understanding of the 
tumor microenvironment and cancer progression through the 
manipulation of physical cues, such as shear stress and interstitial 
flow, introduced through the vessel and the additional coculture 
of other relevant cell types within the surrounding matrix (e.g., 
tumor-associated macrophages, neutrophils, and fibroblasts).
In summary, advances in tumor cell biology, 3D cell culture, 
tissue engineering, biomaterials, microfabrication, and microflu-
idics have enabled rapid development of in vitro tumor models. 
Variations of traditional models are characterized by increased 
complexity through the incorporation of multiple cell types 
(coculture), ECM materials, and spatial and temporal introduc-
tion of soluble factors. Other innovations include incorporation 
of vessels to introduce tumor vasculature, since these leaky tumor 
vessels tend to influence cancer progression and drug transport. 
The development of 3D tumor culture systems is bridging the 
gap between in vitro and in vivo methods for drug screening as 
in vitro 3D models continue to develop to be better indicators of 
in vivo drug efficacy.
The drive toward precision medicine has resulted in increased 
interest in adapting in  vitro tumor models for patient-specific 
therapies, clinical management, and assessment of metastatic 
potential. The next generation of in  vitro tumor models will 
include combinations of existing models and the incorporation 
of new technologies for specific applications. In particular, devel-
opments in the field of organogenesis in combining a source of 
precursor cells that self-organize into a specific tissue or organ 
may be exploited in new tumor models.
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